Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction CancerJianming Xu, Hongyu Zhang, Yongqian Shu et al.|JAMA|2023Cited by 384
Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ studyLin Yang, Yuankai Shi, Wen Zhang et al.|EBioMedicine|2024Cited by 10
A phase II study evaluating KN026 monotherapy in patients (pts) with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancers (GC/GEJC).Jianming Xu, Qian Wang, Rongrui Liu et al.|Journal of Clinical Oncology|2022Cited by 6